Harikesh Pushpapathan
Dr Geoff Waring

ESG needs better disclosure standards

Fund managers should be subject to more rigorous standards to ensure their disclosures about environmental, social and governance (ESG) investing are accurate, according to Stoic Venture Capital. Dr Geoff Waring, Stoic Venture Capital partner, said Australia should take the lead of the United States, European Union and United Kingdom by ramping up its scrutiny of […]

Stoic Venture Capital commits further to healthcare following Cardihab success

Stoic Venture Capital has committed to further bulking up its healthcare investments as the prevalence of chronic disease such as cardiovascular disease continues to rise.Stoic Venture Capital Managing Partner Geoff Waring said Stoic was committed to increasing its healthcare and life science holdings while most other venture capital firms focused predominantly on software.Stoic Venture Capital […]

Demand for diversity and ESG driving investors towards venture capital

More investors are prioritising investments that generate positive social outcomes and avoiding or divesting assets that harm the environment or community such as fossil fuels and gambling.Stoic Venture Capital Partner Geoff Waring said more investors were turning to socially responsible investing strategies that allocate more towards companies in sectors such as healthcare and technology addressing […]

ESG demand driving investors towards venture capital

More investors are turning to responsible investing strategies that allocate towards fledging companies in healthcare and technology, according to a venture capital firm. Stoic Venture Capital partner Geoff Waring commented he has seen more investors have been drawn towards investing in nimble and fast-growing start-ups that target environmental and social concerns, particularly climate change.The demand […]

Disasters push ‘social investing’ demand

Rio Tinto’s chief executive was last year forced to step down following an investor backlash, after the global miner blasted some of the world’s oldest Indigenous heritage sites in Western Australia. Financial services giant AMP faced a similar situation, losing its chairman and two top executives after criticism from major shareholders over its handling of […]

Immigration program revamp can help venture capital firms commercialise university research

Australian venture capital firms could assist Australia’s economic recovery by investing more in commercialising the valuable intellectual property developed by universities. Stoic Venture Capital Partner and member of the Uniseed Investment Committee Dr Geoff Waring said not enough seed stage venture capital was allocated to the commercialisation of university intellectual property. While established late-stage venture […]

Investing in health science start-ups helping to cure Addicted Australia

Stoic Venture Capital and Uniseed have increased their investment in Kinoxis Therapeutics Pty Ltd, an Australian start-up which is developing a revolutionary drug treatment for addiction. Recent television series Addicted Australia revealed Australia’s critical problem with addiction and substance abuse. Stoic Venture Capital is the Co-Investment Fund of Uniseed, a commercialisation fund which focuses on […]

Call to drive innovation by creating beta-testing sites for researchers

12 January 2021 Business News Releases NEW SOUTH WALES could significantly increase technological innovation and new product development by creating beta-testing sites for university researchers. that is the view of Stoic Venture Capital partner Geoff Waring, who said “technology innovation lifts employment while improving competitiveness of local companies at a global level”. “Creating a policy for beta-testing […]

Call to drive innovation by creating beta-testing sites for researchers

12 January 2021 Business News Releases NEW SOUTH WALES could significantly increase technological innovation and new product development by creating beta-testing sites for university researchers. that is the view of Stoic Venture Capital partner Geoff Waring, who said “technology innovation lifts employment while improving competitiveness of local companies at a global level”. “Creating a policy for beta-testing […]

Exonate initiates phase 1b/2 clinical trial for diabetic macular oedema

Cambridge, UK; 2nd February 2021 – Exonate, an mRNA therapy company focused on retinal diseases, today announced that in collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, the first patient has been dosed with Exonate’s lead compound, EXN 407, in a Phase Ib/II clinical trial of patient volunteers with […]

PERKii launches Sparkling Probiotic Drink Nationally at Coles Express

Australian probiotic brand PERKii is excited to launch its new 100% plant-based Sparkling Probiotic Drinks into Coles Express stores nationally. PERKii Sparkling is bottled with 1 billion plant-based probiotics, blended with natural flavours. PERKii’s point of difference is its Targeted Release Probiotics. Micro-shielded to resist stomach acid, for a targeted in-gut release of probiotics. The […]

PERKii launches Sparkling Probiotic Drink Nationally at Coles Express

Australian probiotic brand PERKii is excited to launch its new 100% plant-based Sparkling Probiotic Drinks into Coles Express stores nationally. PERKii Sparkling is bottled with 1 billion plant-based probiotics, blended with natural flavours. PERKii’s point of difference is its Targeted Release Probiotics. Micro-shielded to resist stomach acid, for a targeted in-gut release of probiotics. The […]

Kinoxis Completes $5M Financing Round and Advances Through Toxicology Studies

• $5m funding round completed with existing shareholders• Successful completion of key pre-clinical toxicology studies• IND meeting and commencement of Phase 1 in first half of 2021• Additional drug series secured from the University of Sydney Melbourne and Sydney, Australia, December 22, 2020: Kinoxis Therapeutics Pty Ltd, a pre-clinical stage biotechnology company developing novel therapies for […]

Ena Respiratory nasal spray reduces Covid-19 viral replication in ferrets

• New preventative nasal spray treatment that was shown to prevent COVID-19 infection and prevent transmission in animals announced• Novel therapy developed by Australian biotech company, Ena Respiratory, shown to significantly reduce COVID-19 virus levels in the nose and throat, in a gold-standard animal study• Reduced COVID-19 replication by up to 96%, study performed by Public […]

Our role in Uniseed

Read about the recent history of Uniseed and Stoic Venture Capital’s role. https://www.linkedin.com/posts/peter-devine-4375b94_the-final-instalment-in-the-4-part-series-activity-6713948310643765248-xb7T